A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection

NCT03253471 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped Strategic decision to discontinue further development of investigational compounds for the treatment of hepatitis C.

Conditions

Interventions

Sponsor

Alios Biopharma Inc.